Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
The Leukemia & Lymphoma Society history
The Leukemia & Lymphoma Society company history timeline
Since 1949, we’ve invested nearly $1.3 billion in groundbreaking research, pioneering many of today’s most innovative approaches.
Originally known as the Robert Roesler de Villiers Foundation, The Leukemia & Lymphoma Society was founded in New York City in 1949 by Rudolph and Antoinette de Villiers after the death of their son Robert from leukemia.
The Foundation’s 1955 annual report stated: "As of this date, leukemia is 100% fatal.
E. Donnall Thomas, MD, conducted the first successful bone marrow transplant on a leukemia patient in 1956.
In 1988, Bruce Cleland assembled a NYC Marathon team to raise money in honor of his daughter, a leukemia survivor.
In 1990, LLS-funded researcher Susan Rabinowe, MD, and others, showed the protein CD20 is consistently present on B-cell chronic lymphocytic leukemia (CLL) cells.
In 1992, LSA awarded Doctor Grupp, a Career Development Special Fellow Award, which he credited with helping to launch his career.
In 1996, LLS-funded investigator Brian Druker, MD, tested a BCR-ABL-blocking drug.
Since 2002, LLS continuously supported research by Jerry Adams, PhD, Andrew Roberts, MBBS, PhD, and colleagues to advance this therapy.
Years later (2004), he led a team of LLS-funded researchers investigating the genetic origins of B-cell non-Hodgkin lymphoma.
In 2016, FDA approved of a new therapy, venetoclax (Venclexta®), for patients with a high-risk form of chronic lymphocytic leukemia.
Rate how well The Leukemia & Lymphoma Society lives up to its initial vision.
The Leukemia & Lymphoma Society jobs
Do you work at The Leukemia & Lymphoma Society?
Does The Leukemia & Lymphoma Society communicate its history to new hires?
The Leukemia & Lymphoma Society competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Autism Speaks | 2005 | $47.6M | 2,016 | 8 |
| March of Dimes | 1938 | $169.3M | 7,500 | 16 |
| Kaiser Family Foundation (KFF) | 1948 | $26.0M | 229 | - |
| American Academy of Dermatology | 1938 | $38.3M | 341 | 1 |
| American College of Physicians | 1915 | $5.0M | 843 | 3 |
| Agency for Healthcare Research and Quality | 1980 | $93.0M | 1,996 | - |
| American Nurses Association | 1896 | $33.0M | 2,017 | 23 |
| National Cancer Institute | - | $5.5B | 3,500 | - |
| Blithewold Mansion | 1999 | $1.9M | 7 | - |
| Silicon Valley Leadership Group | 1978 | $5.0M | 84 | 11 |
The Leukemia & Lymphoma Society history FAQs
Zippia gives an in-depth look into the details of The Leukemia & Lymphoma Society, including salaries, political affiliations, employee data, and more, in order to inform job seekers about The Leukemia & Lymphoma Society. The employee data is based on information from people who have self-reported their past or current employments at The Leukemia & Lymphoma Society. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by The Leukemia & Lymphoma Society. The data presented on this page does not represent the view of The Leukemia & Lymphoma Society and its employees or that of Zippia.
The Leukemia & Lymphoma Society may also be known as or be related to Leukemia & Lymphoma Society, The Leukemia & Lymphoma Society and The Leukemia & Lymphoma Society, Inc.